Perfusion Estimates for Simulation Study
| Perfusion† (mL/min/g) | Perfusion estimate* (mL/min/g) | |||
|---|---|---|---|---|
| WNLR | NRE | Patlak analysis | Ideal WNLR | |
| 0.250 | 0.245 ± 0.165 | 0.293 ± 0.135 | 0.282 ± 0.139 | 0.269 ± 0.116 |
| MAVRE (%) | 33.3 | 24.0 | 31.7 | 25.4 |
| 0.500 | 0.465 ± 0.199 | 0.532 ± 0.176 | 0.532 ± 0.215 | 0.512 ± 0.158 |
| MAVRE (%) | 22.2 | 19.0 | 24.3 | 17.7 |
| 0.750 | 0.712 ± 0.264 | 0.781 ± 0.219 | 0.793 ± 0.302 | 0.761 ± 0.212 |
| MAVRE (%) | 19.2 | 16.5 | 21.1 | 15.8 |
| 1.000 | 0.962 ± 0.338 | 1.036 ± 0.274 | 1.047 ± 0.356 | 1.021 ± 0.261 |
| MAVRE (%) | 17.9 | 16.6 | 19.5 | 14.5 |
| 2.000 | 1.922 ± 0.477 | 2.005 ± 0.407 | 2.073 ± 0.546 | 2.008 ± 0.385 |
| MAVRE (%) | 13.6 | 12.0 | 14.8 | 10.9 |
| 3.000 | 2.890 ± 0.581 | 2.994 ± 0.552 | 3.073 ± 0.685 | 2.997 ± 0.482 |
| MAVRE (%) | 11.1 | 11.6 | 13.6 | 9.7 |
| 4.000 | 3.897 ± 0.624 | 4.014 ± 0.661 | 4.057 ± 0.696 | 3.993 ± 0.523 |
| MAVRE (%) | 9.7 | 10.1 | 11.5 | 8.3 |